newsfilter
← Latest News
GlobeNewswire·

Prevail Therapeutics Announces IND Active for PR001 for Treatment of Neuronopathic Gaucher Disease

NEW YORK, Dec. 26, 2019 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL) (“Prevail” or the “Company”), a biotechnology company developing potentially disease-modifying AAV-based gene...